Sd-021, derivatives of decursin, inhibits tumorigenesis in NSCLC by inhibiting the EGFR/STAT3 signaling pathway

Abstract Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a significant challenge in oncology despite advances in targeted and immune-based therapies. NSCLC accounts for approximately 85% of all lung cancer cases, with five-year survival rates ranging from 4 to 17%, depending on...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Hyun-Ha Hwang, Jeong-Hui Je, Hyeong-Chan Lee, Ji-Sung Yoo, Taehyoun Kim, Jung Hwan Choi, Jin Won Hong, Hae-In Lim, Ga Yoon Kim, Yun-Beom Sim, Kwang-Jin Cho, Eun-wook Choi, Chunhoo Cheon, Jae Yeol Lee, Seong-Gyu Ko
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2025-07-01
Reeks:	Scientific Reports
Onderwerpen:	Sd-021 Decursin derivatives Non-small cell lung cancer (NSCLC) EGFR/STAT3 signaling pathway
Online toegang:	https://doi.org/10.1038/s41598-025-05715-5
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!